180 Life Sciences Corp. Profile Avatar - Palmy Investing

180 Life Sciences Corp.

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor ne…

Biotechnology
US, Palo Alto [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

180 Life Sciences Corp. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

180 Life Sciences Corp. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of 180 Life Sciences Corp..

End of ATNF's Analysis
CIK: 1690080 CUSIP: 68236V104 ISIN: US68236V3024 LEI: - UEI: -
Secondary Listings
ATNF has no secondary listings inside our databases.